CENTURY THERAPEUTICS INC (IPSC) Stock Balance Sheet
NASDAQ:IPSC • US15673T1007
Current stock price
2.06 USD
-0.01 (-0.48%)
At close:
2.0011 USD
-0.06 (-2.86%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 61.85M | 58.44M | 47.32M | 84.30M | 56.40M | |||
| Marketable Securities | 55.26M | 130.85M | 125.41M | 231.20M | 166.40M | |||
| Receivables | 667.00K | 1.52M | N/A | N/A | N/A | |||
| Other Current Assets | 2.99M | 3.24M | 4.26M | 4.20M | 5.30M | |||
| Total Current Assets | 120.77M | 194.05M | 176.99M | 319.70M | 228.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 66.17M | 90.85M | 92.08M | 111.70M | 69.80M | |||
| Investments And Advances | 0.00 | 30.82M | 89.10M | 51.90M | 135.90M | |||
| Intangibles | 34.20M | 34.20M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.57M | 3.30M | 2.52M | 3.20M | 3.50M | |||
| Total Non-Current Assets | 102.94M | 159.16M | 183.70M | 166.80M | 209.20M | |||
| TOTAL ASSETS | 223.70M | 353.22M | 360.69M | 486.50M | 437.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 6.50M | 1.00M | |||
| Accrued Expenses | 11.68M | 17.39M | 10.12M | 9.80M | 6.00M | |||
| Accounts Payable | 4.77M | 3.08M | 2.74M | 5.50M | 7.60M | |||
| Other Current Liabilities | 3.78M | 109.32M | 4.98M | 8.00M | 1.00M | |||
| Total Current Liabilities | 20.23M | 129.78M | 17.85M | 29.80M | 15.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 3.70M | 8.90M | |||
| Deferred Taxes/Income | 4.30M | 4.37M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 40.24M | 57.70M | 158.09M | 150.30M | 16.60M | |||
| Total Non-Current Liabilities | 44.54M | 62.07M | 158.09M | 154.00M | 25.40M | |||
| TOTAL LIABILITIES | 64.77M | 191.85M | 175.94M | 183.80M | 41.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -791.92M | -782.34M | -655.77M | -519.10M | -388.20M | |||
| Additional Paid In Capital | 950.81M | 943.37M | 840.41M | 824.30M | 785.00M | |||
| Common Shares | 9.00K | 9.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 30.00K | 324.00K | 108.00K | -2.50M | -700.00K | |||
| Shares Outstanding | 87.52M | 85.84M | 60.34M | 58.50M | 55.00M | |||
| Tangible Book Value per Share | 1.43 | 1.48 | 3.06 | 5.17 | 7.20 | |||
| Total Shareholders' Equity | 158.94M | 161.36M | 184.75M | 302.70M | 396.20M | |||
| TOTAL LIABILITIES AND EQUITY | 223.70M | 353.22M | 360.69M | 486.50M | 437.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | 0.02 | |||
| Current Ratio | 5.97 | 1.50 | 9.92 | 10.73 | 14.54 | |||
| Return On Assets (ROA) | -4.28% | -35.83% | -37.89% | -26.91% | -21.91% | |||
| Return On Equity (ROE) | -6.03% | -78.44% | -73.98% | -43.25% | -24.18% | |||
All data in USD , ROIC based on taxRate of 0.21